Insider Trading activities of Dexcom Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $4,721,044.
The total value of stock sales since 2005 is $539,675,318.
The total value of stock option exercises since 2005 is $34,498,305.



Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-01-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 10,532 11.33 119,327
2015-01-26 Balo Andrew K (EVP, Clinical, Regulatory &) Sale 15,001 59.24 888,734
2015-01-26 Balo Andrew K (EVP, Clinical, Regulatory &) Option Ex 15,001 6.87 103,101
2015-01-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 4,000 58.22 232,864
2015-01-23 Doubleday Richard (EVP, Chief Commercial Officer) Option Ex 4,000 6.03 24,120
2015-01-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 57.78 808,920
2015-01-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-01-20 Moy Jeffrey (SVP, Operations) Sale 5,000 57.58 287,905
2015-01-20 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.80 49,000
2015-01-20 Roper Jess (SVP, CFO) Sale 7,000 57.33 401,303
2015-01-20 Roper Jess (SVP, CFO) Option Ex 6,000 7.63 45,780
2015-01-15 Gregg Terrance H (Executive Chairman) Sale 15,000 57.84 867,555
2015-01-13 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 9,468 62.22 589,136
2015-01-13 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 9,468 11.33 107,272
2015-01-12 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 20,000 59.18 1,183,540
2015-01-12 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 20,000 11.33 226,600
2015-01-09 Valdes Jorge A (CTO) Sale 926 58.53 54,198
2015-01-08 Lister John (Sr. VP, General Counsel) Sale 5,039 57.42 289,339
2015-01-08 Lister John (Sr. VP, General Counsel) Option Ex 5,039 4.58 23,078
2015-01-08 Valdes Jorge A (CTO) Sale 8,244 57.44 473,494
2015-01-08 Valdes Jorge A (CTO) Option Ex 8,244 13.45 110,881
2015-01-05 Moy Jeffrey (SVP, Operations) Sale 5,000 55.27 276,370
2015-01-05 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.80 49,000
2014-12-26 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 55.27 552,690
2014-12-26 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-12-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 54.69 218,776
2014-12-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-12-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 54.62 764,736
2014-12-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.71 107,940
2014-12-18 Roper Jess (VP, CFO) Sale 12,000 56.43 677,148
2014-12-18 Roper Jess (VP, CFO) Option Ex 11,000 7.63 83,930
2014-12-15 Lister John (Sr. VP, General Counsel) Option Ex 4,000 4.58 18,320
2014-12-15 Gregg Terrance H (CEO) Sale 35,000 53.23 1,862,980
2014-12-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-12-12 Lister John (Sr. VP, General Counsel) Sale 3,079 53.55 164,868
2014-12-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-12-12 Sayer Kevin R (President & COO) Sale 10,000 53.97 539,700
2014-12-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 55.42 554,200
2014-12-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-12-08 Valdes Jorge A (CTO) Sale 16,000 56.03 896,512
2014-12-08 Valdes Jorge A (CTO) Option Ex 16,000 7.25 116,000
2014-12-03 Topol Eric (Director) Sale 20,000 55.00 1,100,000
2014-12-02 Gregg Terrance H (CEO) Sale 25,000 53.09 1,327,225
2014-12-02 Gregg Terrance H (CEO) Option Ex 25,000 6.07 151,750
2014-11-28 Gregg Terrance H (CEO) Sale 25,000 52.04 1,301,000
2014-11-28 Gregg Terrance H (CEO) Option Ex 25,000 7.90 197,500
2014-11-26 Gregg Terrance H (CEO) Sale 34,990 51.15 1,789,843
2014-11-26 Gregg Terrance H (CEO) Option Ex 34,990 8.95 313,160
2014-11-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 51.11 511,140
2014-11-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-11-25 Gregg Terrance H (CEO) Sale 20,010 51.00 1,020,510
2014-11-25 Gregg Terrance H (CEO) Option Ex 20,010 8.95 179,089
2014-11-24 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 8,000 50.36 402,896
2014-11-24 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 8,000 6.03 48,240
2014-11-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 22,500 50.74 1,141,627
2014-11-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 22,500 14.14 318,150
2014-11-24 Gregg Terrance H (CEO) Sale 35,000 51.06 1,787,030
2014-11-24 Gregg Terrance H (CEO) Option Ex 35,000 8.95 313,250
2014-11-21 Gregg Terrance H (CEO) Sale 10,000 50.50 505,000
2014-11-21 Gregg Terrance H (CEO) Option Ex 10,000 8.95 89,500
2014-11-19 Gregg Terrance H (CEO) Sale 10,000 51.00 510,000
2014-11-19 Gregg Terrance H (CEO) Option Ex 10,000 8.95 89,500
2014-11-17 Gregg Terrance H (CEO) Sale 35,000 52.52 1,838,305
2014-11-17 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-11-14 Gregg Terrance H (CEO) Sale 10,000 52.51 525,080
2014-11-14 Gregg Terrance H (CEO) Option Ex 10,000 8.95 89,500
2014-11-12 Lister John (Sr. VP, General Counsel) Sale 3,078 52.81 162,558
2014-11-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-11-12 Gregg Terrance H (CEO) Sale 25,000 54.01 1,350,350
2014-11-12 Gregg Terrance H (CEO) Option Ex 25,000 8.95 223,749
2014-11-11 Moy Jeffrey (SVP, Operations) Sale 4,000 53.00 212,000
2014-11-11 Moy Jeffrey (SVP, Operations) Option Ex 4,000 9.80 39,200
2014-11-11 Roper Jess (VP, CFO) Sale 20,000 52.93 1,058,540
2014-11-11 Roper Jess (VP, CFO) Option Ex 20,000 7.63 152,600
2014-11-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 52.93 529,300
2014-11-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-11-11 Gregg Terrance H (CEO) Sale 55,000 53.06 2,918,465
2014-11-11 Gregg Terrance H (CEO) Option Ex 55,000 8.95 492,249
2014-11-11 Lord Jonathan T Md (Director) Sale 18,058 53.09 958,608
2014-11-11 Lord Jonathan T Md (Director) Option Ex 18,058 7.78 140,491
2014-11-10 Valdes Jorge A (CTO) Sale 16,000 51.23 819,712
2014-11-10 Valdes Jorge A (CTO) Option Ex 16,000 7.25 116,000
2014-10-27 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 42.98 429,760
2014-10-27 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-10-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 43.58 174,308
2014-10-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-10-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 43.60 610,456
2014-10-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.63 106,820
2014-10-20 Roper Jess (VP, CFO) Sale 8,000 41.18 329,464
2014-10-20 Roper Jess (VP, CFO) Option Ex 8,000 7.63 61,040
2014-10-15 Gregg Terrance H (CEO) Sale 35,000 39.63 1,386,980
2014-10-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-10-13 Lister John (Sr. VP, General Counsel) Sale 3,400 40.41 137,404
2014-10-13 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-10-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 40.42 404,170
2014-10-13 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-10-08 Valdes Jorge A (CTO) Sale 16,000 40.29 644,656
2014-10-08 Valdes Jorge A (CTO) Option Ex 16,000 7.25 116,000
2014-09-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 40.71 407,070
2014-09-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-09-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 40.31 161,260
2014-09-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-09-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 40.32 564,480
2014-09-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.63 106,820
2014-09-18 Roper Jess (VP, CFO) Sale 8,000 41.91 335,304
2014-09-18 Roper Jess (VP, CFO) Option Ex 8,000 7.71 61,680
2014-09-15 Lister John (Sr. VP, General Counsel) Option Ex 5,500 4.58 25,190
2014-09-15 Gregg Terrance H (CEO) Sale 35,000 41.14 1,439,970
2014-09-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-09-12 Lister John (Sr. VP, General Counsel) Sale 3,518 43.70 153,740
2014-09-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-09-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 42.97 429,709
2014-09-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-09-08 Valdes Jorge A (CTO) Sale 16,000 42.98 687,744
2014-09-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-08-28 Kahn Barbara (Director) Sale 4,000 44.52 178,092
2014-08-26 Moy Jeffrey (SVP, Operations) Sale 16,663 45.25 754,000
2014-08-26 Moy Jeffrey (SVP, Operations) Option Ex 16,663 8.06 134,387
2014-08-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 16,000 44.84 717,520
2014-08-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 16,000 20.65 330,400
2014-08-26 Gregg Terrance H (CEO) Sale 5,000 46.05 230,265
2014-08-26 Lord Jonathan T Md (Director) Sale 20,000 45.56 911,240
2014-08-26 Lord Jonathan T Md (Director) Option Ex 20,000 7.78 155,600
2014-08-25 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 44.35 177,408
2014-08-25 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-08-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 44.24 619,332
2014-08-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.63 106,820
2014-08-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 44.12 441,240
2014-08-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.63 76,300
2014-08-22 Balo Andrew K (SVP, Regulatory and Clinical) Sale 20,000 44.24 884,720
2014-08-22 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 20,000 3.19 63,800
2014-08-22 Gregg Terrance H (CEO) Sale 13,607 44.47 605,062
2014-08-22 Gregg Terrance H (CEO) Option Ex 6,107 6.85 41,832
2014-08-21 Kahn Barbara (Director) Sale 2,200 43.42 95,524
2014-08-21 Valdes Jorge A (CTO) Sale 10,671 43.58 465,042
2014-08-21 Gregg Terrance H (CEO) Sale 6,393 43.50 278,095
2014-08-21 Gregg Terrance H (CEO) Option Ex 6,393 6.85 43,792
2014-08-20 Gregg Terrance H (CEO) Sale 17,500 44.67 781,725
2014-08-20 Gregg Terrance H (CEO) Option Ex 17,500 6.85 119,875
2014-08-19 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 20,000 45.01 900,280
2014-08-19 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 20,000 9.80 196,000
2014-08-19 Gregg Terrance H (CEO) Sale 75,000 45.08 3,381,075
2014-08-19 Gregg Terrance H (CEO) Option Ex 75,000 6.33 474,750
2014-08-18 Roper Jess (VP, CFO) Sale 8,000 43.95 351,632
2014-08-18 Roper Jess (VP, CFO) Option Ex 8,000 7.79 62,320
2014-08-18 Gregg Terrance H (CEO) Sale 75,000 44.15 3,310,875
2014-08-18 Gregg Terrance H (CEO) Option Ex 65,000 6.46 419,900
2014-08-15 Gregg Terrance H (CEO) Sale 5,000 44.06 220,290
2014-08-15 Gregg Terrance H (CEO) Option Ex 5,000 6.85 34,250
2014-08-14 Gregg Terrance H (CEO) Sale 25,000 44.25 1,106,175

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.